Alnylam Pharmaceuticals
ALNY
#437
Rank
C$74.00 B
Marketcap
C$560.18
Share price
1.85%
Change (1 day)
61.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company